Toshiyuki Yoshio Selected Research

Fibrinolytic Agents (Antithrombotic Agents)

7/2022	Antithrombotics increase bleeding after endoscopic submucosal dissection for gastric cancer: Nationwide propensity score analysis.
10/2021	Timing of bleeding and thromboembolism associated with endoscopic submucosal dissection for gastric cancer in Japan.
1/2021	Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score.
1/2021	Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study.
9/2017	Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection.
12/2016	Clinical problems with antithrombotic therapy for endoscopic submucosal dissection for gastric neoplasms.
5/2015	Endoscopic submucosal dissection in early gastric cancer in elderly patients and comorbid conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshiyuki Yoshio Research Topics

Disease

14	Neoplasms (Cancer) 04/2022 - 03/2007
11	Hemorrhage 07/2022 - 01/2013
10	Stomach Neoplasms (Stomach Cancer) 01/2022 - 05/2015
7	Esophageal Squamous Cell Carcinoma 12/2021 - 06/2017
4	Esophageal Neoplasms (Esophageal Cancer) 11/2021 - 04/2016
3	Fistula 01/2022 - 01/2021
3	Thromboembolism 10/2021 - 01/2013
3	Chronic Renal Insufficiency 10/2021 - 05/2015
3	Neoplasm Metastasis (Metastasis) 08/2018 - 07/2010
3	Ulcer 01/2018 - 05/2006
2	Deglutition Disorders (Dysphagia) 01/2022 - 01/2022
2	Esophageal Stenosis (Esophageal Stricture) 01/2022 - 09/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 05/2015
2	Rectal Neoplasms (Rectal Cancer) 01/2018 - 11/2011
2	Thrombosis (Thrombus) 12/2016 - 01/2013
2	Stomach Ulcer (Gastric Ulcer) 01/2008 - 05/2006
1	Pathologic Constriction (Stenosis) 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2021
1	Anastomotic Leak 01/2021
1	Polyps 08/2020
1	Breast Neoplasms (Breast Cancer) 08/2018
1	Lobular Carcinoma 08/2018
1	Cicatrix (Scar) 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2017
1	Hypersensitivity (Allergy) 01/2017
1	Infections 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Atrial Fibrillation 12/2016
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2016
1	Barrett Esophagus (Barrett's Esophagus) 05/2016
1	Pneumonia (Pneumonitis) 09/2015
1	Mediastinal Emphysema (Pneumomediastinum) 09/2015
1	Diabetes Mellitus 02/2015
1	Lymphoid Leukemia 02/2012
1	Splenic Rupture 02/2012
1	Splenomegaly 02/2012
1	Familial duodenal atresia 11/2011
1	Gallbladder Neoplasms (Gallbladder Cancer) 11/2011
1	Ileus 08/2010

Drug/Important Bio-Agent (IBA)

7	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2022 - 05/2015
6	Warfarin (Coumadin)FDA LinkGeneric 11/2021 - 09/2017
5	AnticoagulantsIBA 10/2021 - 12/2016
3	Heparin (Liquaemin)FDA LinkGeneric 09/2017 - 01/2013
2	Cilostazol (Pletal)FDA LinkGeneric 10/2021 - 01/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2021 - 01/2021
2	Dabigatran FDA Link 01/2021 - 09/2017
2	Gemcitabine FDA Link 11/2011 - 08/2010
2	Acetic Acid (Vinegar)FDA LinkGeneric 01/2008 - 05/2006
1	Pharmaceutical PreparationsIBA 05/2022
1	BESIBA 01/2022
1	IodineIBA 11/2021
1	thienopyridineIBA 10/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2021
1	Menthol FDA Link 06/2021
1	Polyglycolic Acid (Polyglycolide)IBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	Purinergic P2Y Receptor AntagonistsIBA 01/2021
1	Factor Xa InhibitorsIBA 01/2021
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2021
1	Thrombin FDA Link 01/2021
1	SolutionsIBA 01/2021
1	Prostaglandins AIBA 01/2021
1	Capsules (Microcapsules)IBA 08/2020
1	Biomarkers (Surrogate Marker)IBA 09/2019
1	Midazolam (Versed)FDA LinkGeneric 01/2019
1	Nucleic AcidsIBA 01/2019
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2019
1	Dexmedetomidine FDA Link 01/2019
1	Proton Pump InhibitorsIBA 01/2018
1	Rabeprazole (Aciphex)FDA Link 01/2018
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2018
1	RivaroxabanIBA 09/2017
1	Penicillins (Penicillin)FDA Link 01/2017
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2016
1	AcidsIBA 05/2016
1	Biological ProductsIBA 01/2016
1	cyclo(Arg-Pro) (CI 4)IBA 09/2015
1	Etoposide (VP 16)FDA LinkGeneric 08/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2010
1	Cisplatin (Platino)FDA LinkGeneric 08/2010

Therapy/Procedure

8	Chemoradiotherapy 01/2022 - 04/2016
7	Therapeutics 01/2021 - 07/2010
6	Drug Therapy (Chemotherapy) 08/2018 - 08/2007
4	Endoscopes 01/2022 - 12/2008
3	Gastrectomy 04/2022 - 12/2009
3	Neoadjuvant Therapy 01/2022 - 06/2017
3	Esophagectomy 12/2021 - 06/2017
3	Renal Dialysis (Hemodialysis) 10/2021 - 02/2015
3	Perioperative Period 01/2021 - 01/2013
2	Stents 01/2022 - 01/2022
2	Bridge Therapy 09/2017 - 12/2016
1	Self Expandable Metallic Stents 01/2022
1	Radiotherapy 01/2022
1	Neck Dissection (Radical Neck Dissection) 03/2017
1	Argon Plasma Coagulation 01/2017
1	Drug-Eluting Stents 12/2016
1	Blood Transfusion (Blood Transfusions) 02/2015
1	Endoscopic Hemostasis 02/2015
1	Splenectomy 02/2012